The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion is a research paper published in Cellular Signalling (2020). On theSindex it has a DataRank of 0.708. It has been cited 111 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.708
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Allergy and Infectious Diseases
Grant: R01AI119131
U.S. Department of Veterans Affairs
Grant: I01-BX004220
American Heart Association
Grant: 15SDG25240022
American Heart Association
Grant: 19TPA34850165
National Institutes of Health
Grant: R01HL136386
National Heart, Lung, and Blood Institute
Grant: R01HL142796
BLRD VA
Grant: I01 BX005845
BLRD VA
Grant: I01 BX004220
BLRD VA
Grant: IK6 BX004016
NHLBI NIH HHS
Grant: R01 HL170056
Harry S. Truman Research Institute for the Advancement of Peace
Office of Research and Development
FWCI
10.37
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords